SHSE:603122's Forward Dividend Yield % is ranked worse than 66.67% of 63
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.11
vs SHSE:603122: 1.16
During the past 12 months, Cowealth Medical China Co's average Dividends Per Share Growth Rate was 116.70% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was -10.30% per year.
During the past 9 years, the highest 3-Year average Dividends Per Share Growth Rate of Cowealth Medical China Co was -10.30% per year. The lowest was -10.30% per year. And the median was -10.30% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Cowealth Medical China Co (SHSE:603122) Forward Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Cowealth Medical China Co Forward Dividend Yield % Related Terms
SHSE:603122 vs TMO, DHR, IDXX: Forward Dividend Yield % Comparison
For the Diagnostics & Research subindustry, Cowealth Medical China Co's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cowealth Medical China Co Forward Dividend Yield % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Cowealth Medical China Co's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Cowealth Medical China Co's Forward Dividend Yield % falls into.
Cowealth Medical China Co Forward Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Cowealth Medical China Co Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
CNY 0.130000
2025-07-14
2025-07-11
2025-07-14
Cash Dividend
annually
CNY:CNY 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Forward Dividend Yield % of 1.16% mean?
Cowealth Medical China Co (SHSE:603122) has a Forward Dividend Yield % of 1.16% as of Jul. 07, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Cowealth Medical China Co and its competitors. According to the industry distribution chart, Cowealth Medical China Co ranks #42 out of 63 companies in the Medical Diagnostics & Research industry, placing it in the top 66.7%.
Is Cowealth Medical China Co's Forward Dividend Yield % too high?
Cowealth Medical China Co's current Forward Dividend Yield % is 1.16%. The Medical Diagnostics & Research industry median Forward Dividend Yield % is 2.11. Cowealth Medical China Co's value of 1.16% is 45% below this industry median. Based on the distribution chart, Cowealth Medical China Co ranks #42 out of 63 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Cowealth Medical China Co has a GF Score™ of 41/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cowealth Medical China Co's Forward Dividend Yield % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Cowealth Medical China Co ranks #42 out of 63 companies for Forward Dividend Yield %. This places Cowealth Medical China Co in the lower half of its industry. The industry median Forward Dividend Yield % is 2.11. Cowealth Medical China Co's value of 1.16% is 45% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Medical Diagnostics & Research company?
The median Forward Dividend Yield % among Medical Diagnostics & Research companies is 2.11, based on 63 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cowealth Medical China Co's current Forward Dividend Yield % of 1.16% is 45% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Cowealth Medical China Co and its competitors. For the Medical Diagnostics & Research industry, the median Forward Dividend Yield % is 2.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cowealth Medical China Co's current Forward Dividend Yield % is 1.16%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cowealth Medical China Co stock overvalued right now?
Based on GuruFocus' analysis, Cowealth Medical China Co (SHSE:603122) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥3.87, compared to a current price of ¥10.49 — trading 171.1% above its estimated fair value. The current Forward Dividend Yield % is 1.16% and 45% below the Medical Diagnostics & Research industry median of 2.11. Cowealth Medical China Co's overall GF Score™ is 41/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Cowealth Medical China Co (SHSE:603122), the current Forward Dividend Yield % is 1.16% as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cowealth Medical China Co (SHSE:603122) Overvalued in 2026?
Based on GuruFocus' analysis, Cowealth Medical China Co stock appears to be overvalued.
The current stock price of ¥10.49 is trading 171.1% above its estimated GF Value™ of ¥3.87.
GuruFocus considers Cowealth Medical China Co to be Significantly Overvalued.
Key valuation signals for SHSE:603122:
Forward Dividend Yield %: 1.16%
GF Value™: ¥3.87 vs. price of ¥10.49 (171.1% above fair value)
Industry Position: 45% below the Medical Diagnostics & Research median (#42 of 63)
No single metric tells the full story. See the SHSE:603122 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603122 has been successfully added to your 